Verlamelin and its new derivative (verlamelin B) were isolated from fermentation broth of entomopathogenic fungus Lecanicillium sp. HF627. As the structural elucidation of verlamelin so far was only preliminary, we studied and determined the absolute structure of these two compounds to be cyclo(5S-hydroxytetradecanoic acid-
INTRODUCTION
Entomopathogenic fungi are fungal parasites of insects. During their infection to insects, they are known to evade insect immunities and kill the host insects by secreting several bioactive substances. [1] [2] [3] As the high productivity has been well established by continuous discovery of novel bioactive compounds, [4] [5] [6] entomopathogenic fungi have been regarded as a source of bioactive compounds. Especially, those belonging to the genus Lecanicillium (formerly Verticillium lecanii) can be good source of novel compounds, as exemplified by the isolation of indolosesquiterpenes (lecanindoles A-D 7 ), phenopicolinic acid derivatives (vertilecanins 8 ) and pregnanes. 9, 10 Here we would like to report isolation and structure determination of two compounds, verlamelin (verlamelin A, 1) and it new derivative (verlamelin B, 2) from entomopathogenic fungus Lecanicillium sp. Although the planar structure of verlamelin has already been reported, its structure determination was only preliminary, because these reports lacked detailed information on the signal assignments of 1 H/ 13 C, the signal connectivity in HSQC/HMBC and the D/L configuration of the component amino acids. [11] [12] [13] Furthermore, the configuration of a hydroxyl group on the 5-hydroxytetradecanoic acid moiety has not yet been determined. Therefore, in order to completely establish the structure of verlamelin, we conducted a detailed structure determination of 1 and 2.
RESULTS AND DISCUSSIONS
Lecanicillium sp. HF627 was cultivated under static conditions in liquid medium containing sucrose 8%, yeast extract 4%, CaCO 3 0.5% and HP20 1%. The whole broth was extracted with n-butanol. Compounds 1 and 2 were purified by a series of steps with silica gel column chromatography, C18 column chromatography and preparative reverse phase HPLCs.
Both major compound 1 and minor compound 2 were obtained as colorless solid. The molecular formula of 1 was identified as C 45 ) , suggesting that 2 is a one-methylene-shorter derivative of 1, considering the almost identical UV/Vis spectrum (l max 224, 278 nm).
All the 13 C signals and all the 1 H signals were assigned using DEPT135, HSQC, COSY and HMBC (Table 1) . 13 C NMR of the two compounds detected eight carbonyl carbons in the range of d C 170-174, and 1 H NMR in DMSO-d 6 revealed eight broad resonances, which were not detectable in the measurement using methanol-d 4 , suggesting that certain numbers of amide linkages were present in these compounds. Overlapping methylene signals in the high magnetic field suggested that both compounds have an alkyl chain. Based on these data, 1 and 2 were assumed to bear typical lipopeptide substructures. By COSY and HMBC correlations, the component amino acids were estimated to be valine (Val), alanine (Ala), tyrosine (Tyr), threonine (Thr) (1) or serine (Ser) (2), glutamine (Gln) and proline (Pro). The remaining substructure was deduced to be a 5-hydroxytetradecanoic acid moiety by comparison of the dc values of C-2 to C-6 with those on cordycommunin, which has the 5-hydroxytetradecanoic acid substructure. 14 As d H of the oxymethine H-5 was detected relatively downfield (4.79 (1), 4.77 (2)), the C-5 was judged to be involved in ester bonding. The connecting sequence of components was finally determined as 5-hydroxytetradecanoic acid, Thr (1) or Ser (2), Ala, Pro, Gln, Tyr and Val, based on HMBC and ROESY (1) and NOESY (2) correlation. HMBC correlation of the oxymethine on 5-hydroxytetradecanoic acid with C-1 on Val demonstrated the formation of a cyclic structure (Figure 1) . Thus, the compound 2 was proposed to be a new analog of verlamelin (verlamelin B) in which Ser was replaced with Thr.
To determine the absolute configurations in the peptide moiety of the verlamelins, Marfey's analysis was conducted. 15 As for the absolute configuration of C-5 in the 5-hydroxytetradecanoic acid moiety, a modified Mosher's method was used. 16, 17 After the reactive phenolic hydroxyl group was protected by methyl iodide and the macrolactone ring was cleaved by methanolysis, the reaction products (purified by C18 HPLC) showed m/z at 932.5 and 918.5, respectively, suggesting that methanolysis proceeded successfully. (Figure 2 ). Based on these results, the absolute structures of verlamelin A and verlamelin B were definitively determined for the first time, as shown in Figure 3 . Based on the previous results of in vitro antifungal activity of verlamelin, [11] [12] [13] we measured the antifungal activity of 1 and 2 by disc diffusion method (summary of results, Supplementary Figure S11 ).
The potency of both compounds was equal when tested against Cochliobolus miyabeanus and Alternalia solani. However, the new derivative of verlamelin, 2 was less active against Fusarium oxysporum, Cladosporium cucumerinum and Ustilago maydis (potency of 2: 4, 0.5 and 464 mg per disc, respectively), compared with 1 (potency of 1: 2, 0.25 and 16 mg per disc, respectively), suggesting that the methyl group on the first amino-acid residue connected to the fatty acid moiety should have an important role for antifungal activities against these fungi. As antifungal spectrum of 1 agreed well with that of the verlamelin reported previously, 13 1 might possess identical absolute configuration to that of the original verlamelin.
By detailed structure determination, the absolute structures of 1 and 2 were identified for the first time; they were found to consist of a cyclic lipodepsipeptide, cyclo(5S-hydroxytetradecanoic acid-D- (Figure 3) . The related compounds, W493 A/B, cyclo(3S-hydroxy-4R-methyltetradecanoic acid-D-alloThr-L-Ala-D-Ala-L-Gln-D-Tyr-L-Val/Ile), from Fusarium sp., 18 and cordycommunin, cyclo(5-hydroxytetradecanoic
, from Ophiocordyceps communis, 14 have also similar partial structure to fengycin (plilastatin A1, inhibitor of phospholipase A 2 ), which was isolated from Bacillus subtilis as an antifungal lipopeptide compound containing a cyclic peptide moiety composed of L- 19, 20 Judging from the correlation of the structure 
EXPERIMENTAL PROCEDURE
General experimental procedure NMR spectra were recorded on a JEOL JMN-ECS400 (JEOL, Tokyo, Japan) at 400 MHz for 1 H and 100 MHz for 13 C. The 1 H and 13 C chemical shifts were referenced to the solvent signal (dH 2.49 and dC 39.5 in dimethyl sulfoxide (DMSO)-d6, dH 3.31 in CD 3 OD). HRFABMS were recorded on a JEOL JMS-700 spectrometer. Optical rotation was measured on a P-1020 polarimeter (Jasco, Tokyo, Japan). The UV spectrum was recorded on a Hitachi U-3200 spectrophotometer (Hitachi, Tokyo, Japan).
Fungal material
The entomopathogenic fungus Lecanicillium sp. HF627 was isolated from a chillie thrips cadaver. Fungal conidia that had developed on the surface of the cadaver were transferred onto solid Sabouraud maltose yeast-extract (SMY) medium (4% maltose, 1% yeast extract, 1% peptone) with 1.5% agar and incubated at 25 1C for several days. After several rounds of single-colony isolation, the isolated strain was identified as Verticillium lecanii (Lecanicillium sp.) according to its morphology. The fungus is deposited at the culture collection of Natural Institute of Fruit Tree Science.
Fermentation and isolation
The seed culture was prepared by inoculating conidia of strain HF627 into 50 ml of SMY medium in a 500-ml baffled flask, followed by cultivation on a rotatory shaker at 28 1C and 160 r.p.m. for 3 days. For the main cultivation, the seed culture (2 ml) was inoculated into 100 ml of Medium #5 (8% sucrose, 4% yeast extract, 0.5% CaCO 3 , 1% activated HP20 (Mitsubishi Chemical Co., Tokyo, Japan) by methanol) in 500-ml Erlenmeyer flasks, followed by static incubation for 21 days at 25 1C. The culture broth (1 liter) was mixed with nbutanol (500 ml) and stirred for 1 h, and the n-butanol layer was collected after centrifugation (3000 r.p.m., 10 min), dried over anhydrous sodium sulfate and concentrated in vacuo using a rotary evaporator, yielding 3 g of brown gum as the crude extract. column (Ø10 Â 250 mm) (Shiseido Co., LTD., Tokyo, Japan) with isocratic elution using 80% methanol at a flow rate of 4 ml min À1 . The peaks of 2 and 1, detected at 11 and 12 min by UV (210 nm), respectively, were collected individually and evaporated in vacuo to dryness, yielding 2.7 and 65.5 mg of colorless amorphous solid, respectively (chromatogram of HPLC, see Supplementary Figure S1 ). Additional quadruplicate experiments without the Sep-Pak Silica fractionation were carried out further to obtain 2. As a result, a total of 97.7 mg of 2 was obtained.
Compound (1) Figures S4 and S5) .
Stereochemistry of amino acids constituting verlamelin A and B
One milligram of aliquots of 1 or 2 were hydrolyzed by heating at 115 1C for 8 h in 10 ml of 6 M HCl. After cooling to room temperature, they were completely dried in vacuo and dissolved in 150 ml of water. Marfey's reagent (300 ml of 10mgml À1 solution in acetone) (N a -(2,4-dinitro-5-fluorophenyl)-L-alaninamide) (Tokyo Chemical Industry Co., Ltd., Tokyo, Japan) was added, followed by the addition of 70 ml of 1 M NaHCO 3 . The reactions proceeded at 37 1C for 1 h and were quenched by addition of 70 ml of 1 M HCl. The resulting mixture was dried in vacuo and then dissolved in 1 ml of DMSO to be analyzed by HPLC. Marfey's derivatives of amino acids as a standard were prepared by reacting 50 mM of amino acids in the same manner as described above. HPLC analysis was carried out on a Shiseido Capcell-Pak C18 column (Ø4.6 Â 250 mm) with a linear gradient of CH 3 CN from 10% to 50% in 0.05% aqueous TFA solution (60 min from 10% to 50%, 5 min at 50%, 3 min from 50% to 10%), at a flow rate of 1.0 ml min À1 , with detection at 340 nm. The glutamine (Gln) residues of 1 and 2 should be converted by acid hydrolysis to glutamic acid (Glu). Retention times (min) of Marfey's derivatives used as standards were as follows: L-Ser (25. A modified Mosher's method using (R)-and (S)-MaNP acid (Tokyo Chemical Industry Co., Ltd.) was used to clarify the stereogenic centers of the hydroxytetradecanoic acid moiety. 16 To protect the hydroxyl group of the Tyr residue in advance, methylation was carried out as follows. To 1 and 2 dissolved in acetonitrile (10 mg per 500 ml) were added 50 ml of 1,8-diazabicyclo [5.4 .0]undec-7-ene and 50 ml of CH 3 I. After incubation at 50 1C for 3 h and quenching by dilution with water, the reaction products were extracted three times with an equal volume of ethyl acetate. The ethyl acetate layer was washed with 1 M HCl and brine, dried over anhydrous sodium sulfate, and concentrated in vacuo, yielding crude methyl ethers of 1 and 2.
To cleave the ester linkage between hydroxytetradecanoic acid and Val residue, methanolysis was carried out as follows. Crude verlamelin methyl ethers were dissolved in 2 ml of 0.5 M methanolic sodium metoxide and stirred for 5 h at room temperature. After quenching with 1 M HCl, extraction with ethyl acetate (equal volume, three times) and evaporation in vacuo, the cleaved product and the uncleaved reactant were collected individually by reverse phase C18 HPLC using 85% methanol as eluent. The recovered reactant was reused for the same reaction, and the product was obtained as described above. The methyl ethers of 1 and 2 yielded 6.2 and 4.2 mg of methanolysis products, respectively.
(R)-and (S)-MaNP acid esters of 1 were prepared as follows. The methanolysis product of 1 methyl ether (in 200 ml of CH 2 Cl 2 ) was mixed with 2 mg of dimethyl amino pyridine, 3 mg of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC), 2 ml of triethyl amine and 2.1 mg of (R)-MaNP acid or 2.1 mg of (S)-MaNP acid. After standing at room temperature overnight and quenching by addition of water, the reaction mixture was extracted three times with an equal volume of ethyl acetate. After washing the ethyl acetate extract with 1 M HCl and brine, drying over anhydrous sodium sulfate and concentrating in vacuo, the (R)-and (S)-MaNP acid ester derivatives of 1 (3a and 3b, respectively) were purified by reverse phase HPLC on a Shiseido Capcell-Pak C18 column (Ø10 Â 250 mm) with isocratic elution using 90% methanol as a mobile phase.
(R)-and (S)-MaNP acid ester derivatives of 2 (4a and 4b, respectively) were synthesized and purified in a similar manner as those of 1. 
